Connect Biopharma Holdings Ltd.(CNTB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CNTB Connect Biopharma Holdings Ltd.

Closed Memorial Day 05-22 16:00:00 EDT

2.35

-0.01

-0.42%

盘后2.35

+0.000.00%

16:10 EDT

High2.45	Low2.32	Vol94.54K
Open2.38	D1 Closing2.36	Amplitude5.51%
Mkt Cap147.97M	Tradable Cap43.41M	Total Shares62.96M
T/O225.48K	T/O Rate0.51%	Tradable Shares18.47M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CNTB","market":"US","secType":"STK","nameCN":"Connect Biopharma Holdings Ltd.","latestPrice":2.35,"timestamp":1779480000000,"preClose":2.36,"halted":0,"volume":94536,"hourTrading":{"tag":"盘后","latestPrice":2.35,"preClose":2.35,"latestTime":"16:10 EDT","volume":8,"amount":18.7712,"timestamp":1779480604903,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.00423728813559313,"floatShares":18470500,"shares":62963853,"eps":-1.154539,"marketStatus":"Closed Memorial Day","change":-0.01,"latestTime":"05-22 16:00:00 EDT","open":2.38,"high":2.45,"low":2.32,"amount":225479,"amplitude":0.055085,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.154539,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1779782400000},"marketStatusCode":7,"adr":0,"adrRate":1,"listingDate":1616126400000,"exchange":"NASDAQ","adjPreClose":2.36,"preHourTrading":{"tag":"盘前","latestPrice":2.48,"preClose":2.36,"latestTime":"09:25 EDT","volume":1135,"amount":2769.066991,"timestamp":1779456333336,"change":0.12,"changeRate":0.050847,"amplitude":0.143093},"postHourTrading":{"tag":"盘后","latestPrice":2.35,"preClose":2.35,"latestTime":"16:10 EDT","volume":8,"amount":18.7712,"timestamp":1779480604903,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6820483961733258,"impliedVol":0.9242,"impliedVolPercentile":0.1633},"requestUrl":"/m/hq/s/CNTB/wiki","defaultTab":"wiki","newsList":[{"id":"2637233236","title":"Connect Biopharma Initiated at Overweight by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2637233236","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637233236?lang=en_us&edition=fundamental","pubTime":"2026-05-21 22:23","pubTimestamp":1779373380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CNTB/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 21, 2026 10:23 ET (14:23 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637382344","title":"Connect Biopharma initiated with an Overweight at Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2637382344","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637382344?lang=en_us&edition=fundamental","pubTime":"2026-05-21 18:11","pubTimestamp":1779358298,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald analyst Olivia Brayer initiated coverage of Connect Biopharma (CNTB) with an Overweight rating and $4 price target Published firs...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/connect-biopharma-initiated-with-an-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/connect-biopharma-initiated-with-an-overweight-at-cantor-fitzgerald-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635903668","title":"Connect Biopharma files to sell 6.13M ordinary shares for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2635903668","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635903668?lang=en_us&edition=fundamental","pubTime":"2026-05-15 23:43","pubTimestamp":1778859834,"startTime":"0","endTime":"0","summary":"08:33 EDT Connect Biopharma (CNTB) files to sell 6.13M ordinary shares for holders Published first on TheFly – the ultimate source for real-time, m...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/connect-biopharma-files-to-sell-6-13m-ordinary-shares-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/connect-biopharma-files-to-sell-6-13m-ordinary-shares-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635084011","title":"Connect Biopharma Holdings Ltd - Proposed Resale of up to 6.1 Mln Ordinary Shares of Connect Biopharma - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2635084011","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635084011?lang=en_us&edition=fundamental","pubTime":"2026-05-15 20:33","pubTimestamp":1778848387,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nFWN41S13I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635754597","title":"Connect Biopharma posts corporate presentation on rademikibart development in asthma, COPD, atopic dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2635754597","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635754597?lang=en_us&edition=fundamental","pubTime":"2026-05-14 06:46","pubTimestamp":1778712417,"startTime":"0","endTime":"0","summary":"Connect Biopharma outlined development plans for rademikibart, an anti-IL-4Rα monoclonal antibody with global rights outside greater China.Phase 2 studies in acute COPD and asthma exacerbations started in 2Q2025, with topline data expected in mid-2026; study is being run by Simcere at no cost to Connect.Simcere filed an NDA in China for atopic dermatitis in July 2025.U.S. FDA agreed rademikibart is ready to move into Phase 3 for chronic treatment of asthma and atopic dermatitis, based on results from completed studies.Presentation highlighted clinical and preclinical comparisons versus dupilumab, including a reported reduction in eosinophils in asthma patients and potential for less frequent dosing in atopic dermatitis.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financia","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260513:nNDL3LV6qv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635000172","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2635000172","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635000172?lang=en_us&edition=fundamental","pubTime":"2026-05-13 18:00","pubTimestamp":1778666400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Copa Hldgs A                                     1Q      4.14    4:30 PM. ·FLEX LNG Ltd                                    1Q       .36    1:00 AM","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACOG","BGSI","CSCO","BN","PHVS","AEBI","ALLO","CMPS","BIRK","BABA","CLPT","BEEM","CCCC","CAAP","CPA","CLBT","CSWC","BBWI","AQST","ATS","BTDR","CNTB","BOOT","BEAT","AKA","BTGO","CLNN","GOOS","ATAT","AUTL","BZAI","AYTU","CING","DERM","CBUS","KARO","PYPD","BTBT","BLSH","CCAP","ABEO","ARX","ALT","CELC","AMAT","AVAH","CSIQ","BWAY","ATYR","BHST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635425246","title":"Connect Biopharma Holdings (CNTB) Gets a Buy from H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2635425246","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635425246?lang=en_us&edition=fundamental","pubTime":"2026-05-13 00:36","pubTimestamp":1778603778,"startTime":"0","endTime":"0","summary":"In a report released today, Brandon Folkes from H.C. Wainwright reiterated a Buy rating on Connect Biopharma Holdings, with a price target of $7.00...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/connect-biopharma-holdings-cntb-gets-a-buy-from-h-c-wainwright-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/connect-biopharma-holdings-cntb-gets-a-buy-from-h-c-wainwright-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634213214","title":"Connect Biopharma Hldgs Q1 EPS $(0.34) Misses $(0.28) Estimate, Sales $169.000K","url":"https://stock-news.laohu8.com/highlight/detail?id=2634213214","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634213214?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:06","pubTimestamp":1778591204,"startTime":"0","endTime":"0","summary":"Connect Biopharma Hldgs (NASDAQ:CNTB) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.28) by 21.43 percent. This is a 78.95 percent decrease over losses of $(0.19) per","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52484446/connect-biopharma-hldgs-q1-eps-0-34-misses-0-28-estimate-sales-169-000k","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634214747","title":"Connect Biopharma Holdings Ltd: Currently Remain on Track to Report Topline Results From Both Seabreeze Stat Studies Mid-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2634214747","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634214747?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:00","pubTimestamp":1778590806,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUA5PPT9F:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634214697","title":"Connect Biopharma Reports First Quarter 2026 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2634214697","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634214697?lang=en_us&edition=fundamental","pubTime":"2026-05-12 21:00","pubTimestamp":1778590806,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260512:nTUA5PPT9F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631686264","title":"Simcere says China regulator accepts NDA for atopic dermatitis drug rademikibart","url":"https://stock-news.laohu8.com/highlight/detail?id=2631686264","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631686264?lang=en_us&edition=fundamental","pubTime":"2026-04-30 16:49","pubTimestamp":1777538955,"startTime":"0","endTime":"0","summary":"Simcere Pharmaceutical Group NDA for IL-4Rα antibody rademikibart accepted for regulatory review by China NMPA for atopic dermatitis in adults and adolescents.Rademikibart was jointly developed with Connect Biopharma Hong Kong.Company cited Phase 3 data showing Week 16 EASI-75 response rate of 74.2%.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Simcere Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 30, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL7gSS7r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB","02096","BK1191","BK1583","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629184472","title":"Northland Securities Remains a Buy on Connect Biopharma Holdings (CNTB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2629184472","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629184472?lang=en_us&edition=fundamental","pubTime":"2026-04-24 21:15","pubTimestamp":1777036553,"startTime":"0","endTime":"0","summary":"Northland Securities analyst Carl Byrnes maintained a Buy rating on Connect Biopharma Holdings today and set a price target of $7.50. Byrnes covers...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/northland-securities-remains-a-buy-on-connect-biopharma-holdings-cntb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/northland-securities-remains-a-buy-on-connect-biopharma-holdings-cntb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629832676","title":"Connect Biopharma Holdings Ltd - Expects to Report Phase 2 Seabreeze Stat Topline Data in Mid-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2629832676","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629832676?lang=en_us&edition=fundamental","pubTime":"2026-04-23 21:08","pubTimestamp":1776949726,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nFWN4160OJ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629622832","title":"Connect Biopharma Holdings: Data Monitoring Committee Reports No Safety Concerns or Treatment-Related Serious Adverse Events in Seabreeze Stat Studies","url":"https://stock-news.laohu8.com/highlight/detail?id=2629622832","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629622832?lang=en_us&edition=fundamental","pubTime":"2026-04-23 21:08","pubTimestamp":1776949726,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nFWN4160OJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629583263","title":"Connect Biopharma Holdings - Enrollment in Phase 2 Seabreeze Stat Studies Will Continue as Planned Following Pre-Specified Interim Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2629583263","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629583263?lang=en_us&edition=fundamental","pubTime":"2026-04-23 21:08","pubTimestamp":1776949726,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nFWN4160OJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629546832","title":"Connect Biopharma Seabreeze STAT Phase 2 trials continue unchanged after interim review","url":"https://stock-news.laohu8.com/highlight/detail?id=2629546832","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629546832?lang=en_us&edition=fundamental","pubTime":"2026-04-23 21:04","pubTimestamp":1776949497,"startTime":"0","endTime":"0","summary":"Connect Biopharma kept Phase 2 Seabreeze STAT asthma and COPD trials for rademikibart on track following a pre-specified interim efficacy review by an independent Data Monitoring Committee.Committee recommended no change to planned sample size, supporting continued enrollment as designed.Safety review flagged no concerns, with no treatment-related serious or severe adverse events reported to date.Topline results have not been presented yet; Connect expects to report topline data from both studies in mid-2026.Positive readouts would position Connect to seek FDA alignment on a Phase 3 program for acute exacerbations of asthma and COPD.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260423:nNDLbhbmPF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","LU2210150020.SGD","CNTB","IE00BN0W2W23.USD","LU2210149790.SGD","SG9999014039.USD","IE00BN0W2V16.EUR","NDAQ","IE00BKPKM429.USD","SG9999014013.SGD","IE00B3QW5Z07.USD","BK4112","IE00BN0W2T93.GBP","IE00B64PRP62.GBP","LU0314104364.USD","LU2095319765.USD","BK4588","IE00BGHQF748.EUR","BK4139","BK4585","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625594833","title":"Analysts Offer Insights on Healthcare Companies: Alpha Cognition Inc (ACOG), Insmed (INSM) and Connect Biopharma Holdings (CNTB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2625594833","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625594833?lang=en_us&edition=fundamental","pubTime":"2026-04-08 18:30","pubTimestamp":1775644248,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Alpha Cognition Inc (ACOG), Insmed (INSM) and Connec...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alpha-cognition-inc-acog-insmed-insm-and-connect-biopharma-holdings-cntb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alpha-cognition-inc-acog-insmed-insm-and-connect-biopharma-holdings-cntb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4588","CNTB","HCSG","LU0109394709.USD","ACOG","XBI","LABU","BK4137","BK4585","XLV","LU0029874061.USD","LU0053671581.USD","BK4139","INSM","LU0128526141.USD","LU0320765992.SGD","LU0889565916.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624522143","title":"Connect Biopharma Price Target Maintained With a $10.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2624522143","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624522143?lang=en_us&edition=fundamental","pubTime":"2026-04-02 12:14","pubTimestamp":1775103240,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CNTB/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 02, 2026 00:14 ET (04:14 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624541590","title":"Connect Biopharma director James Huang acquires $4 million common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2624541590","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624541590?lang=en_us&edition=fundamental","pubTime":"2026-04-02 04:31","pubTimestamp":1775075497,"startTime":"0","endTime":"0","summary":"Connect Biopharma director James Huang reported purchase of 1,160,000 ordinary shares at $3.45.Indirect beneficial ownership rose to 13,160,000 ordinary shares following transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Connect Biopharma Holdings Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 01, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL9zKrpC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Connect Biopharma director James Huang acquires $4 million common shares","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CNTB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624518475","title":"Connect Biopharma Holdings Ltd reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2624518475","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624518475?lang=en_us&edition=fundamental","pubTime":"2026-04-01 06:58","pubTimestamp":1774997906,"startTime":"0","endTime":"0","summary":"Connect Biopharma Holdings Ltd reports results for the quarter ended December 31 - Earnings SummaryConnect Biopharma Holdings Ltd CNTB.OQ reported a quarterly adjusted loss of 27 fen per share for the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nL8N40J2KZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNTB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.connectbiopharm.com","stockEarnings":[{"period":"1week","weight":-0.0126},{"period":"1month","weight":-0.0962},{"period":"3month","weight":-0.1132},{"period":"6month","weight":-0.227},{"period":"1year","weight":1.8519},{"period":"ytd","weight":-0.1667}],"compareEarnings":[{"period":"1week","weight":0.0088},{"period":"1month","weight":0.0484},{"period":"3month","weight":0.0815},{"period":"6month","weight":0.1314},{"period":"1year","weight":0.2788},{"period":"ytd","weight":0.0934}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on developing therapies to treat T cell-driven inflammatory diseases. The company is building a pipeline of small molecules and antibodies using functional T cell assays to screen and discover potent product candidates against validated immune targets. Its lead product candidate is CBP-201, an antibody to target interleukin-4 receptor alpha in development for the treatment of atopic dermatitis (AD) and asthma. The company's product candidates also comprise CBP-307, a modulator of S1P1 T cell receptor and is in development for the treatment of ulcerative colitis; and CBP-174, a peripherally acting antagonist of histamine receptor 3 in development for the treatment of pruritus associated with skin inflammation. Connect Biopharma Holdings Limited was founded in 2012 and is headquartered in San Diego, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.028496},{"month":2,"riseRate":0.6,"avgChangeRate":-0.025044},{"month":3,"riseRate":0.4,"avgChangeRate":-0.062942},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.024639},{"month":5,"riseRate":0.5,"avgChangeRate":-0.068685},{"month":6,"riseRate":0.8,"avgChangeRate":0.091691},{"month":7,"riseRate":0.4,"avgChangeRate":0.150673},{"month":8,"riseRate":0.8,"avgChangeRate":0.204473},{"month":9,"riseRate":0.2,"avgChangeRate":-0.084295},{"month":10,"riseRate":0.4,"avgChangeRate":0.007717},{"month":11,"riseRate":0.2,"avgChangeRate":-0.108453},{"month":12,"riseRate":1,"avgChangeRate":0.142382}],"exchange":"NASDAQ","name":"Connect Biopharma Holdings Ltd.","nameEN":"Connect Biopharma Holdings Ltd.","securityTypeName":"DR","adrRate":"1:1"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Connect Biopharma Holdings Ltd.(CNTB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Connect Biopharma Holdings Ltd.(CNTB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Connect Biopharma Holdings Ltd.,CNTB,Connect Biopharma Holdings Ltd.股票,Connect Biopharma Holdings Ltd.股票老虎,Connect Biopharma Holdings Ltd.股票老虎国际,Connect Biopharma Holdings Ltd.行情,Connect Biopharma Holdings Ltd.股票行情,Connect Biopharma Holdings Ltd.股价,Connect Biopharma Holdings Ltd.股市,Connect Biopharma Holdings Ltd.股票价格,Connect Biopharma Holdings Ltd.股票交易,Connect Biopharma Holdings Ltd.股票购买,Connect Biopharma Holdings Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Connect Biopharma Holdings Ltd.(CNTB),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Connect Biopharma Holdings Ltd.(CNTB) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}